Announcements Trials

Browse Landscape

Phase

Phase 2 2 Phase NA 1 Phase 4 1

Status

Recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 580 Neoplasms 488 Prostatic Neoplasms 311 Lung Neoplasms 236 Colorectal Neoplasms 199 Motor Activity 131 Carcinoma, Non-Small-Cell Lung 117 Uterine Cervical Neoplasms 112 Brain Neoplasms 110 Pancreatic Neoplasms 109 Head and Neck Neoplasms 106 Stomach Neoplasms 99 Carcinoma, Hepatocellular 98 Rectal Neoplasms 97 Ovarian Neoplasms 86 Colonic Neoplasms 86 Neoplasm Metastasis 67 Multiple Myeloma 65 Esophageal Neoplasms 65 Hematologic Neoplasms 62 Urinary Bladder Neoplasms 60 Glioblastoma 59 Melanoma 58 Sarcoma 57 Precursor Cell Lymphoblastic Leukemia-Lymphoma 57 Endometrial Neoplasms 56 Glioma 53 Lymphoma 50 Leukemia, Myeloid, Acute 48 Gastrointestinal Neoplasms 48

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Recruiting × Hemangioblastoma × Clear all

NCT05424016 2023-12-13

PRO-HEB

Assistance Publique - Hôpitaux de Paris

Phase NA Recruiting

von Hippel-Lindau Disease, Hemangioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡